Factors associated with a low HIV reservoir in patients with prolongedsuppressive antiretroviral therapy

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 3, 2014, Pages 753-756

  Fourati, Slim ^a,b   Flandre, Philippe ^a,b   Calin, Ruxandra ^c   Carcelain, Guislaine ^a,b   Soulie, Cathia ^a,b   Lambert Niclot, Sidonie ^a,b   Maiga, Almoustapha ^d   Ait Arkoub, Zaina ^b   Tubiana, Roland ^a,b   Valantin, Marc Antoine ^a,b   Autran, Brigitte ^a,b,e   Katlama, Christine ^a,b,e   Calvez, Vincent ^a,b,e   Marcelin, Anne Genevieve ^a,b,e  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c ORVACS   (France)

^d and Technologies of Bamako   (Mali)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Antiretroviral therapy; Art; HIV immunity

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MONONUCLEAR CELL; PROCEDURES; PROVIRUS; RETROSPECTIVE STUDY; VIROLOGY; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROVIRUSES; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

EID: 84894035657     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt428     Document Type: Article

References (16)

1. Chun TW, Stuyver L, Mizell SB et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997; 94: 13193-7.
2. Wong JK,HezarehM,Gunthard HFet al. Recoveryof replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278: 1291-5.
3. Finzi D, Hermankova M, Pierson T et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278: 1295-300.
4. ChunTW, Justement JS, Moir S et al. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. J Infect Dis 2007; 195: 1762-4.
5. Hocqueloux L, Avettand-Fenoel V, Jacquot S et al. Long-termantiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. J Antimicrob Chemother 2013; 68: 1169-78.
6. Siliciano JD, Kajdas J, Finzi D et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 2003; 9: 727-8.
7. ChunTW, Nickle DC, Justement JS et al. HIV-infected individuals receiving effective antiviral therapyforextended periods of timecontinually replenish their viral reservoir. J Clin Invest 2005; 115: 3250-5.
8. Lambert-Niclot S, Flandre P, Valantin MA et al. Factors associated with virological failure in HIV-1-infected patients receiving darunavir/ritonavir monotherapy. J Infect Dis 2011; 204: 1211-6.
9. Piketty C, Weiss L, Assoumou L et al. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir. J Med Virol 2010; 82: 1819-28.
10. Yerly S, Gunthard HF, Fagard C et al. Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions. AIDS 2004; 18: 1951-3.
11. Avettand-Fenoel V, Chaix ML, Blanche S et al. LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01). J Med Virol 2009; 81: 217-23.
12. Saez-Cirion A, Bacchus C, Hocqueloux L et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013; 9: e1003211.
13. Chun TW, Justement JS, Murray D et al. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 2010; 24: 2803-8.
14. Ananworanich J, Vandergeeten C, Chomchey N et al. Early ART intervention restricts the seeding of the HIV reservoir in long-lived central memory CD4T cells. In: Abstracts of the Twentieth Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 2013. Abstract 47. Foundation for Retrovirology and Human Health, Alexandria, VA, USA.
15. Williams JP, Hurst J, Robinson N et al. HIV-1 DNA levels after antiretroviral therapy in primary infection predict disease progression: the SPARTAC Trial. In: Abstracts of the Seventh IAS Conference on HIV Pathogenesis, Treatment and Prevention, Kuala Lumpur, 2013. Abstract WELBA04.
16. ChunTW, Justement JS, Pandya P et al. Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. J Infect Dis 2002; 185: 1672-6.